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1. Introduction 
Shleifer and Vishny (2003) claim that overvalued firms can increase shareholder wealth by using 
their stock as currency to purchase less overvalued firms.1 Recent empirical evidence seems to support the 
proposition that many stock-financed acquisitions are driven by acquirer stock overvaluation. For instance, 
Rhodes-Kropf, Robinson, and Viswanathan (2005), Dong, Hirshleifer, Richardson, and Teoh (2006), Ang 
and Cheng (2006) show that stock-swap acquirers are more overvalued than their targets before merger 
announcements (on average) and that the level of equity overvaluation increases a firm’s probability of 
becoming a bidder using stock as the method of payment.  
Although using stock-swap acquisitions to exploit mispricing is appealing hypothetically, we 
challenge the notion that acquirer shareholders benefit in practice. The existence of relative overvaluation 
between the acquirer and target stocks before the announcement, as documented by previous studies, is a 
necessary, but not a sufficient condition, for the acquisition to benefit acquirer shareholders. For acquirer 
shareholders to benefit from using their overvalued stock as currency in an acquisition, the acquirer must 
be able to lock in its relative stock overvaluation (compared to the target) by negotiating a favorable 
exchange ratio (i.e., pay a low premium). Furthermore, any synergies associated with the deal (which 
Shleifer and Vishny assume in their model are positive) must not be so negative as to offset any benefit 
from the overvaluation-induced favorable exchange ratio.  
We show that overvalued acquirers often significantly overpay for the targets they purchase, and, 
more importantly, these acquisitions do not produce the necessary synergy gains. We also compare the 
long-run operating and stock price performance of these overvalued acquirers against that of similarly 
overvalued industry peers that are not involved in acquisitions. This comparison suggests that 
shareholders of overvalued acquirers would actually benefit if their firms had not pursued the acquisitions 
                                                 
1 Why would the target agree to a stock swap with an overvalued acquirer? Shleifer and Vishny (2003) argue that 
this could be driven by different investor horizons, extrapolation, or agency problems at target firms. Rhodes-Kropf 
and Viswanathan (2004) suggest that target managers over-estimate synergies due to incomplete information. We do 
not specifically address this question, but instead focus on the hypothetical benefits to acquirer shareholders. 
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in our sample. Combined, our evidence casts doubt on shareholder wealth creation being the main motive 
behind these acquisitions. Our investigation further reveals that overvalued acquirers have weak corporate 
governance and that the CEOs of overvalued acquirers experience significant increases in option-based 
compensation following their acquisitions. Increasing CEO compensation, as opposed to creating 
shareholder wealth, appears to be the motive behind these acquisitions. 
Our paper offers different conclusions from another recent paper in this literature. Savor and Lu 
(2009) focus on a small sample of announced, but later withdrawn, acquisitions and report that 
unsuccessful stock acquirers earn lower long-run stock returns than successful stock acquirers do. They 
conclude that there is value to success in a stock acquisition, arguing that this supports the hypothesis that 
“… overvalued firms create value for long-term shareholders by using their equity as currency” (abstract).  
However, even if consummating a merger is better than failing to do so (as Savor and Lu claim), this 
does not necessarily serve the goal of creating value for acquirer shareholders, since there may be a better 
alternative when stock is substantially overvalued: a seasoned equity offering (SEO). It is not particularly 
meaningful to compare two inferior choices (completing versus withdrawing an announced acquisition) if 
managers’ goal is to create value for shareholders. As Shleifer and Vishny (2003) recognize, in the 
absence of substantial merger synergies, this goal might be better served through an SEO. 
What principally drives the differences between their paper and ours is that Savor and Lu (2009) 
implicitly assume that all announced stock acquisitions are motivated by acquirer overvaluation. This is 
not the case. In our sample, we estimate that approximately one-third of stock deals are not motivated by 
acquirer stock overvaluation: Acquirer stocks are either not overvalued or not more overvalued than the 
target stocks. We exclude these deals in our examination of deals driven by acquirer stock overvaluation. 
Savor and Lu’s assumption (that all stock acquirers are overvalued) taints their relatively small sample of 
failed mergers, and makes it difficult to identify the true effect of acquirer overvaluation. Moreover, the 
counterfactual we will use (similarly overvalued industry peers not involved in an acquisition) more 
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directly addresses the issue than theirs (failed acquirers in “exogenously” failed mergers) does because we 
hold constant a proxy for the empirical measure at the heart of this matter (acquirer overvaluation) while 
Savor and Lu assume all acquirers are similarly overvalued. 
In this paper we study mergers and acquisitions of U.S. firms announced and completed between 
1985 and 2006. Unlike previous studies, we identify stock-swap mergers for which the acquirer has the 
largest relative stock price overvaluation compared to the target before the acquisition announcement. If 
there are acquisitions by overvalued acquirers that produce the benefits suggested in Shleifer and Vishny 
(2003), these deals are likely to provide the best examples. In this sub-sample, we find that the acquirer’s 
overvaluation relative to the target, though substantial before the announcement, quickly dissipates once 
the deal is announced.  
The disappearance of relative overvaluation is driven by both a decrease in the acquirer’s stock price 
and an increase in the target’s stock price. The decrease in the acquirer’s stock price might be triggered by 
overpayment and/or lack of synergies, but it could also reflect investors’ correction of acquirer 
overvaluation at announcement. The latter is unlikely to be detrimental to long-term shareholders if such a 
correction would occur in time anyway. Because of these potentially confounding effects, however, we do 
not rely on acquirer announcement returns to assess benefits to acquirer shareholders. In contrast, the 
target stock price movement conveys more meaningful information about the premium offered (as 
suggested in Schwert, 1996), and it is net of the market correction of acquirer overvaluation. Compared to 
the targets in other acquisitions, targets in acquisitions by overvalued acquirers realize significantly higher 
premiums and secure more favorable exchange ratios compared to the pre-merger acquirer and target 
relative prices. These higher premiums are not explained by differences in deal, acquirer, or target 
characteristics, suggesting significant overpayment to targets by overvalued acquirers.  
To examine synergies, we evaluate operating performance following acquisitions by overvalued 
acquirers. We fail to find evidence of positive synergies. Instead, merged firms in these acquisitions suffer 
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deterioration in operating ROA and asset turnover, while such deterioration is not found, or is 
substantially less severe, for acquirers in acquisitions not driven by overvaluation. Our evidence therefore 
demonstrates that overvalued acquirers make poor choices of targets in acquisitions and are unsuccessful 
in turning their substantial pre-merger relative overvaluation advantage into favorable terms in the 
consummated deal. 
We ask whether shareholders of overvalued acquirers would have been better off had the firms not 
pursued acquisitions. To answer this counterfactual question, for each overvalued acquirer we identify a 
contemporaneous control firm that is in the same industry, and has similar size, Tobin’s q, stock return in 
the previous year, and, most importantly, a similar valuation multiple, but does not pursue a merger or an 
equity offering. We compare the operating and return performance of the overvalued acquirers to the 
performance of the control firms. Overvalued acquirers incur significantly worse stock returns during the 
five years following acquisitions than the control firms that did not engage in mergers. Overvalued 
acquirers also experience significant deterioration in operating performance, which is not observed in the 
control firms over the same period.  
Our results lead us to the question of what motivates overvalued acquirers to buy less-overvalued 
targets if there is little shareholder wealth creation. Following Harford and Li (2007), we find that 
acquirer CEOs in overvaluation-driven acquisitions obtain substantial pecuniary benefits following these 
transactions, specifically large new restricted stock and option grants. These large increases in 
compensation often outweigh the relatively small decreases in the value of the CEO’s equity holding in 
the acquiring firm. We also find evidence that overvalued acquiring firms have weak governance 
structures prior to their acquisition attempts. These findings are consistent with Jensen’s (2005) 
hypothesis that equity overvaluation generates substantial agency costs for shareholders (especially if 
unchecked due to weak structural governance): in this case the pursuit of acquisitions would make CEOs, 
but not shareholders, better off. 
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Taken together, our findings cast significant doubt on the effectiveness of acquirers’ use of 
temporarily overvalued stock in stock-swap mergers and acquisitions: such acquisitions do not appear to 
benefit acquirer shareholders in any tangible way. Furthermore, our evidence suggests that shareholders, 
but perhaps not the CEO, would be better off if the overvalued firm did not pursue such an acquisition.  
Our study contributes to several recent strands of the M&A literature. In a small sub-sample of 
mergers and acquisitions between 1998 and 2001, Moeller, Schlingemann, and Stulz (2005) show that 
acquirer shareholders, in aggregate, lose $240 billion during the three-day announcement period, 
principally in acquisitions by what appear to be overvalued acquirers (high market-to-book). Our paper is 
different from theirs in that we examine a larger sample of overvalued acquirers over a longer period of 
time.2 Moreover, they focus on announcement returns (and thus wealth implications for short-horizon 
investors) and do not differentiate between investors’ correction of overvaluation and real value 
destruction.  
Several recent papers examine the wealth effects of acquisitions for overvalued acquirers, taking 
different perspectives that result in conclusions that are broadly consistent with ours. Gu and Lev (2011) 
find that acquisitions driven by equity overvaluation frequently trigger large goodwill write-offs in the 
years following the acquisition, concluding that overvalued acquirers make systematically worse 
acquisition decisions than acquirers that are not overvalued. Akbulut (2012) and Song (2007) use acquirer 
managers’ personal trading decisions to infer overvaluation (instead of the market-/accounting-based 
metrics we use), examine the relation with long-run abnormal stock returns, and similarly conclude that 
such deals are unlikely to benefit acquirer shareholders. In contrast to their papers, however, we also 
investigate the specific mechanisms of value destruction (substantial overpayment and lack of synergies) 
and, more importantly, why these valuing destroying acquisitions are allowed to occur (weak governance). 
                                                 
2 We select our sample of interest using measures of the relative overvaluation of the bidder to the target, while 
Moeller, Schlingemann, and Stulz (2005) select their sample by year; they tend to focus on the notable outliers of 
value destruction in acquisitions occurring at a particular point in time, while our analysis is concerned with the 
mean outcome from acquisitions occurring over a long period of time. 
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2. Data  
Our mergers and acquisitions data are obtained from the Securities Data Company’s (SDC) U.S. 
database.  We use the following criteria to select the final sample: 
1) The acquisition is announced and completed between 1985 and 2006. 
2) Both the acquirer and target are public firms listed on the NYSE, AMEX, or Nasdaq. 
3) The deal value is at least $10 million (in 2006 dollars) and at least 1% of the acquirer’s market 
value of equity. 
4) The acquirer controls less than 50% of the target’s shares prior to the announcement and owns 
100% of the target’s shares after the transaction. 
5) The method of payment is either 100% cash or 100% stock.3 
6) Both the acquirer and target have positive book value of assets (AT) and book value of equity 
(CEQ) in Compustat as of the end of the fiscal year prior to announcement, and share price and 
shares outstanding data available in the CRSP (to compute market-to-book (assets) ratios). 
The final sample has 1,319 stock-financed and 671 cash-financed mergers or acquisitions. Table 1 reports 
the number of acquisitions by the calendar year of acquisition announcement. Consistent with extant 
studies, there are concentrations of deal activity in the late 1980s and, especially, the late 1990s. Cash-
financed acquisitions appear relatively more popular in the 1980s, but in the bull-market M&A wave of 
the late 1990s the number of acquisitions financed by stock vastly outnumbers those financed with cash 
(although this trend appears to have reversed following the market crash in 2001). 
                                                 
3 Mixed method-of-payment deals are not included in our sample because it is difficult to determine the wealth 
effects of stock overvaluation when the method of payment is partially (overvalued) stock and partially cash. 
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3. Identifying acquisitions motivated by stock overvaluation 
A necessary condition for a stock-swap acquisition to be motivated by overvaluation is that the stock 
of the acquirer is more overvalued than the stock of the target. Using various measures of equity 
overvaluation, previous studies find that, based on the stock prices before acquisition announcements, 
acquirers in stock swaps are more overvalued than their targets on average. However, whether an acquirer 
can turn this relative, pre-announcement overvaluation into actual gains after the merger for their 
shareholders depends on the premium paid to the target and the potential synergies from the deal.  
We start the empirical analysis by confirming existing findings in the literature: specifically, that 
overvalued equity appears to motivate stock-swap acquisitions. We employ the measure of misvaluation 
derived in Rhodes-Kropf, Robinson, and Viswanathan (2005, hereafter RRV). They decompose a firm’s 
log market-to-book equity ratio (Ln(M/B)) into two components:  
   
 
 
     
 
 
     
 
 
         (1) 
where M is the market value of equity, B is the book value of equity, and V stands for the intrinsic value 
of equity. V is unobservable but can be estimated from a linear function of the firm’s book value of equity, 
net income, and leverage. The first component, Ln(M/V), proxies for misvaluation. The details of the 
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decomposition methodology can be found in the Appendix of this paper, or in RRV (2005). 4  This 
decomposition has also been adopted in recent studies such as Hertzel and Li (2010).5  
Measuring stock overvaluation based on publicly available information is impossible if markets are 
perfectly efficient. Shleifer and Vishny (2003) however assume inefficient markets, and overvaluation 
measures similar to the ones we employ are used by Rhodes-Kropf, Robinson, and Viswanathan (2005) 
and Ang and Cheng (2006) to provide evidence in support of Shleifer and Vishny’s hypothesis that 
acquisitions by overvalued acquirers benefit shareholders. We do not directly address the issue of market 
efficiency in this paper. Instead, we show that even if stock overvaluation is measurable, high premiums 
and negative operating synergies typically make deals driven by acquirer stock overvaluation unattractive 
for long-term acquirer shareholders. 
Table 2 reports the valuation ratios of merging firms at different dates around the transaction, in 
particular, 42 trading days before the acquisition announcement, one day before the acquisition 
announcement, and on the day of deal completion. Schwert (1996) suggests that, due to information 
leakage and market anticipation, stock prices of the merging firms may partially reflect the value 
implications of the merger in the two months prior to announcement. Therefore our first measure of 
market value is 42 trading days before the announcement. The book value of equity is the same for all 
these measures, and is measured as of the end of the fiscal year ending immediately prior to the merger 
announcement date.  
                                                 
4 Our main results are robust to measuring misvaluation in two other ways: (i) the Fama and French (1997) 48-
industry-adjusted market-to-book ratio of equity; or (ii) differences between market values and intrinsic values 
derived using the residual income model in Ohlson (1995) (as in Lee, Myers, and Swaminathan, 1999, and Dong, et 
al., 2006). The correlation between any pair of these three misvaluation measures is over 0.60, and we find very 
similar empirical results based on classifying acquirers into groups based on the three measures of overvaluation. 
For the sake of brevity, therefore, we focus on the results based on the RRV measure (i.e., Eq. (1) above), although 
results based on the other misvaluation metrics are available from the authors by request. 
5 The decomposition described in the Appendix results in an ordering of acquirers based on the sum of firm-level 
and industry-level mispricing. However, it might be more meaningful (in terms of testing hypothesis in Shleifer and 
Vishny, 2003) to order acquirers by firm-level misvaluation only. When we use firm-level mispricing only as our 
measure of misvaluation we obtain results (available upon request) that are practically identical to those presented in 
the remainder of this paper. It is perhaps not surprising that our results do not change much since 83% of the 
acquirers and targets in our sample are in the same Fama-French 12 industry category, implying that industry-level 
mispricing does not drive much of the difference in misvaluation. We thank the referee for this suggestion. 
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Prior to merger announcements, bidders have significantly higher market-to-book equity ratios than 
their targets (1.02 vs. 0.71), but the difference seems due to mispricing (0.50 vs. 0.13 at day -42). At 42 
trading days prior to bid announcements, stock bidders are overvalued by more than cash bidders (0.58 vs. 
0.32). Targets in stock-swap acquisitions are also overvalued before the merger announcements, while 
targets in cash acquisitions appear to be fairly valued on average. Although both acquirers and targets in 
stock-financed mergers are overvalued on average before announcement (on both day -42 and day -1), 
acquirers tend to be more overvalued than their targets (e.g., 0.60 vs. 0.26 one trading day prior to 
announcement). Overall, our results are consistent with the empirical evidence in Rhodes-Kropf, 
Robinson, and Viswanathan (2005), Dong, Hirshleifer, Richardson, and Teoh (2006), and Ang and Cheng 
(2006). The dominant overvaluation of acquirers relative to targets in stock swaps appears consistent with 
Shleifer and Vishny’s (2003) explanation of the motivation for stock-financed acquisitions.6  
This relative overvaluation diminishes quickly as the merger progresses towards completion, however. 
In particular, the difference in Ln(M/V) between the acquirer and target in stock-financed mergers drops 
by 80% from 0.39 at 42 trading days before the announcement to 0.08 on the day of deal completion. This 
substantial narrowing of the relative overvaluation is reflective of the general fact that acquirers’ stock 
prices fall and target stock prices rise during the bid period. This however does not imply that acquirers 
fail to capture the benefits of relative overvaluation at announcement. As long as the exchange ratio in the 
merger is set taking into account pre-announcement acquirer and target stock prices (and the merger does 
not yield too negative synergies), the acquirer could still, theoretically, take advantage of their overvalued 
stock to buy cheap(er) target assets. Whether this is the case is an empirical question that we will turn to 
shortly. 
                                                 
6 However, the stock of cash bidders is also more overvalued than the stock of their targets before the merger and 
the relative overvaluation is of similar magnitude as in stock-swap deals. If relative overvaluation is the most 
important determinant of the bidder’s choice of the method of payment, it is puzzling why these cash bidders did not 
use stock as the method of payment. The fact that these bidders choose to use cash, despite the relative overvaluation 
of their equity, suggests that there are other factors affecting the choice of payment method. 
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Although Shleifer and Vishny (2003) suggest that overvaluation may motivate a firm to pursue a 
stock-financed acquisition, they do not argue that every stock-financed acquisition is motivated by the 
acquirer’s overvaluation relative to the target.
7  The results in Table 2 suggest the importance of 
conditioning on relative overvaluation when testing their hypothesis. Relative overvaluation (ROV) is 
measured as the difference in Ln(M/V) between the acquirer and target (as in Table 2) 42 trading days 
prior to the merger announcement. For 404 stock acquisitions (out of 1,319 in Table 1: 31% of our 
sample), we find that either the acquirer is not more overvalued than its target or the acquirer is not 
overvalued in absolute terms (i.e., Ln(M/V) for the acquirer is less than zero). We deem it inappropriate 
to classify these stock acquisitions as motivated by acquirer overvaluation.  
Therefore, we focus in most of the paper on the remaining stock acquisitions in which the acquirers 
are a) overvalued in absolute terms 42 trading days prior to the merger announcement; and b) are more 
overvalued than their respective target 42 trading days prior to the merger announcement. Further, in 
order to sharpen our tests and to mitigate the impact of potential measurement errors, we exclude the 
bottom half of the distribution (within this subsample) based on the ranking of the relative overvaluation 
measure (ROV). We are left with a subsample of 425 stock-swap acquisitions satisfying these criteria; in 
terms of acquisitions motivated by stock overvaluation, these acquisitions should fit Shleifer and Vishny’s 
hypothesis the best – acquirers are overvalued in absolute terms and substantially more overvalued than 
their targets. For the purpose of exposition, we denote these 425 stock acquisitions as “OV acquisitions” 
(i.e., acquisitions likely driven by stock overvaluation) and the 404 stock acquisitions not seemingly 
driven by overvaluation (using the criteria above) as “NOV acquisitions”.
8 
                                                 
7 Savor and Lu (2009) do not differentiate between the various motives of stock acquisitions and implicitly assume 
that all stock-financed mergers are motivated by acquirer stock overvaluation. 
8 By definition, the sample of NOV acquisitions includes deal in which the target is more overvalued than the 
acquirer. Acquisitions in this subset of NOV deals are especially punitive for acquirer shareholders: for example, in 
untabulated analysis we find that the average cumulative abnormal announcement return for acquirers is 
significantly positive if deals in which the target is more overvalued than the acquirer are excluded (compared to 
zero if they are not). To avoid data snooping, however, we retain the full set of NOV acquisitions in the remainder 
of this paper, but note that none of our results are qualitatively affected by the exclusion of these deals from our 
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Table 3 presents some key characteristics of the merging firms in the fiscal year prior to the 
acquisition announcement, divided into these three groups (OV stock acquisitions, NOV stock 
acquisitions, and cash acquisitions). Bidders in NOV stock acquisitions are smaller than bidders in either 
of the other deal-type categories, measured using total assets or market value of equity, although the 
targets are generally not significantly different in size. Somewhat mechanically bidders in OV 
acquisitions have significantly higher median valuation (P/E) ratios and pre-deal stock returns (market-
adjusted 12-month return) than bidders in NOV and cash-financed deals. Interestingly, however, such 
high valuations and returns of OV bidders appear to be unrelated to accounting fundamentals, as OV 
bidders do not have higher operating ROA, leverage, or asset turnover (but do have significantly higher 
sales growth) than NOV stock bidders and cash bidders. Consistent with findings in the literature, cash 
acquisitions tend to be more hostile, more likely to involve competing bidders, involve tender offers, have 
bidders with toehold, and be diversifying deals. There is also some evidence in the table that cash 
acquisitions are less likely to occur in waves. 
One concern with the time-series of OV acquisitions is that it might consist of primarily acquisitions 
in the market bubble period of the late 1990s, as that is when there are a large number of stock-financed 
acquisitions by overvalued acquirers (e.g., Moeller, Schlingemann, and Stulz (2005)). The results in this 
paper would be less meaningful if the OV group of acquisitions contained mostly acquisitions from that 
unusual time period. We therefore examine the distribution of these three groups of acquisitions over time. 
While there is some concentration in OV acquisitions during the 1997 – 2000 period (216 (51%) out of 
425 OV acquisitions), this four year period is one in which there is a concentration of stock-financed 
acquisitions in general (585 (44%) out of the 1,319 stock-financed acquisition in the sample described in 
Table 1). Furthermore, of the 752 acquisitions in Table 1 between 1997 and 2000, 29% are in the OV 
                                                                                                                                                             
sample. We thank the referee for suggesting this analysis to us, and leave a thorough analysis of deals in which the 
target is more overvalued than the acquirer to future research. 
12 
group, 19% in the NOV group, and 22% are cash financed.9 Therefore, this suggests that OV acquisitions 
are not overly concentrated in the market bubble period of the late 1990s relative to the general 
concentration of stock-financed acquisitions in this period (and the general correlation of acquisition 
activity with periods of economic prosperity). Moreover, acquisitions in this unusual period (the late 
1990s) are not overrepresented by acquisitions in the OV group.  
As a further test, in untabulated results (available from the authors by request) we regress the measure 
of relative overvaluation (ROV) on year indicator variables. The results suggest that acquirers are more 
overvalued than their targets on average for most of the period 1997 – 2000, but are also significantly 
relatively overvalued in non-bubble years such as 2002 and 1985. We interpret the results from this 
analysis as supporting the conclusions offered above: in the market bubble period of the late 1990s 
acquirers were relatively more overvalued than their targets, but by no means are acquirers more 
overvalued than their targets only during that period. 
 
4. Do overvalued acquirers overpay? 
As long as the acquirer’s stock is more overvalued than the target’s stock, a stock-swap acquisition 
could benefit acquirer shareholders. As an ex-ante motivation for stock acquisitions, however, this 
justification overlooks one important fact: acquirers often pay a significant premium to take over their 
targets. As a result, price movements in the acquirer (down sharply) and target (up sharply) shares may 
shrink, or even eliminate, the relative overvaluation that initially motivates the acquisition. If the terms of 
acquisition, specifically the exchange ratio at which target stock is converted into acquirer stock, are 
determined based on the relative valuation before announcement, the acquiring firm may be able to lock 
in the transactional gains from acquiring hard (target) assets using (more) overvalued paper. However, 
                                                 
9 These percentages do not add up to 100% because we have excluded some stock acquisitions with low, positive 
relative overvaluation (i.e., those that did not make it into either the OV or NOV groups described above) and not all 
the acquisitions in Table 1 have enough information to compute relative overvaluation measures. 
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whether overvalued acquirers can do so depends critically on whether the acquirer overpays the target 
with too high of a premium. 
To address this question we estimate two different measures of the acquisition premium (AP) paid by 
the acquirer. The first measure is based on the stock returns of the target during the bid period, as in 
Schwert (1996). One advantage of this measure is that the increase in the target’s stock price will, in an 
efficient market, reflect the true premium offered by the acquirer net of any correction of acquirer stock 
mispricing. Following Schwert (1996) we compute this measure of acquisition premium as the target 
cumulative abnormal returns (CAR) from 42 trading days before the announcement to the day of deal 
completion (i.e., the bid period),  
                       
 
          (3) 
where t=0 for the day of announcement and t=T for the date of deal completion. This measure of 
acquisition premium is also used in Bargeron, Schlingemann, Stulz, and Zutter (2008). For completeness, 
we also report the three-day announcement CARs for targets (another popular measure of value creation 
in the M&A literature) and the bid-period CAR for acquirers. 10 
Our second measure of acquisition premium is the exchange ratio divided by the relative price of the 
target and acquirer stock before announcement. In particular, 
     
              
                             
       .                                          (4) 
Exchange ratio is defined as the number of acquirer shares exchanged for each share of target stock. The 
denominator is the relative price of the target and acquirer shares 42 trading days prior to the 
                                                 
10 We follow the standard event study methodology to compute cumulative abnormal return (CAR). Specifically, we 
use the CRSP value-weighted index as the market portfolio, estimate the parameters of the market model using 
returns from trading day -253 to trading day -42, and use the estimated parameters to compute the expected return 
during the event window. The daily pricing errors (the differences between realized returns and estimated expected 
returns) are cumulated over the event window to compute CARs. The three-day event window is counted from day -
1 to day +1 relative to the announcement day. 
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announcement day (AD). This measure is calculated only for stock-swap acquisitions, and exchange ratio 
data is from SDC and hand-checked for every stock-swap in our sample. 
As reported in Table 4, both measures of acquisition premium yield consistent results. The average 
premium paid by OV stock acquirers to their target is significantly higher than the premium paid by NOV 
stock acquirers. The difference is as large as 15% using the AP1 premium measure (based on target stock 
returns), and is even larger if the second measure (AP2) is used. The premiums paid by OV acquirers 
appear to be comparable to those paid by cash acquirers. Cash acquirers are known to offer significantly 
higher premiums than stock acquirers for their targets (Jensen and Ruback, 1983), potentially explained 
by the incidence of hostile acquisitions (which often involve cash payments) and the fact that cash offers 
trigger an immediate tax liability for target shareholders (and hence require a compensating premium). 
The three-day announcement returns for target shareholders suggest the same conclusion: higher 
premiums paid by overvalued acquirers using their own stock as a method of payment. 
Consistent with the acquisition premium results, in Table 4 we find that OV stock-swap acquirers 
incur very negative abnormal returns during the bid period (-17% at the mean and -11% at the median). In 
contrast, NOV stock acquirers and cash acquirers do not realize negative cumulative abnormal returns on 
average during the bid period. 
Another interesting comparison is between acquisitions by the same acquirers that are classified as 
OV acquirers at some point in time in our sample period and as NOV acquirers at other times. In other 
words, we examine subsamples of our OV and NOV data where each OV acquirer has at least one other 
deal where they are classified as a NOV acquirer (with a minimum of 6 months between deals by the 
same acquirer with different valuation classification). In these subsamples with common acquirers we 
have 77 OV deals and 63 NOV deals. The deals in these subsamples have significantly different 
premiums: for example, using AP1 acquirers pay premiums of 37.8% on average when they are 
overvalued (OV) compared to 20.7% premiums on average when they are not. Acquirers also incur 
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significantly more negative announcement abnormal returns at times when they are overvalued (OV) 
relative to when they appear in the NOV subsample. Our results are consistent with those for the 
unconstrained samples presented in Table 4: acquirers pay more in acquisitions when they are overvalued 
relative to the premiums paid when they are not.11  
Next we use regression analysis to examine if the variation in acquisition premiums can be explained 
by the differences in target, acquirer, and deal characteristics (reported in Table 3). The dependent 
variable in our regressions is the acquisition premium (AP1 or AP2 above). In some of the specifications 
we include an indicator variable (OV) as the variable of interest. This variable is equal to one if the deal is 
an OV acquisition (as in Table 4), and zero otherwise. In other specifications we directly include the 
relative overvaluation measure (ROV) described in Section 3.12 We use similar control variables as in 
Bargeron, Schlingemann, Stulz, and Zutter (2008). The regression samples contain only stock-swap 
acquisitions because AP2 (Eq. (4) above) is not defined for cash deals, but our regressions with AP1 as the 
dependent variable are qualitatively unaffected if we use a sample containing both stock and cash mergers.   
Table 5 presents the regression results. In Columns 1 and 4 the principal explanatory variable of 
interest is the OV indicator, and controlling for acquirer, target, and deal characteristics, OV stock 
acquirers tend to pay an average premium of around 10 percentage points higher than other bidders do. 
These coefficients are statistically significantly different from zero, and relatively stable regardless of 
whether AP1 or AP2 is used as the dependent variable. In Columns 2 and 5 in the table we replace the OV 
indicator with the continuous measure of relative overvaluation, ROV, and also add year fixed effects to 
the regressions.  The coefficients on the ROV variable are positive and highly statistically significant in 
both the AP1 and AP2 regressions, suggesting again that acquisition premiums are increasing in acquirer 
overvaluation relative to the target. In terms of economic magnitude, using the point estimate in Column 2 
(with AP1 as the dependent variable, which is net of the correction of acquirer misvaluation at the 
                                                 
11 We thank the referee for suggesting these tests. Unfortunately the small sample sizes (and resulting loss of power) 
prevent us from obtaining significant results for the other metrics in Table 4 (AP2 and target three-day CARs). 
12 We thank the referee for suggesting this approach. 
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announcement) a one standard deviation increase in acquirer relative overvaluation (ROV) is associated 
with a 10.0 percentage point increase in premiums. Given that the unconditional average premium 
(calculated as in AP1) for stock-swap acquisitions is 27.4%, this represents an economically substantial 
increase in premiums associated with a one standard deviation increase in acquirer overvaluation. 
In Columns 3 and 6 we add acquirer fixed effects to the regressions. The effect of this addition is to 
allow us to make within-firm comparisons for acquirers that appear multiple times in the data, and 
estimate how their relative overvaluation (ROV) at different points in time affect their tendency to 
overpay. Similar to the univariate evidence discussed above, we find evidence consistent with the notion 
that the same acquirer pays significantly higher premiums in acquisitions undertaken when they are more 
overvalued. 
The coefficients on the control variables are largely consistent with prior literature, with higher 
premiums being paid by large acquirers, to small targets, by acquirers with low leverage (and hence more 
financial flexibility), and in hostile deals. We also observe a markup-pricing effect (Schwert, 1996) in our 
sample: the coefficients on the prior 12-month return to the target stock are significantly negative but far 
smaller than -1. 
In summary, our results suggest that the characteristics of the merging firms and the deal terms that 
they agree on are unable to explain the significantly higher premiums paid by overvalued bidders. In other 
words, overvalued stock acquirers substantially overpay their targets, and this overpayment is net of 
investors’ correction of acquirer stock overvaluation. However, it is possible that the overpayment we 
document is justified by significant merger synergies. In the next section we examine post-acquisition 
operating performance to assess acquisition synergies directly. 
 
5. Do acquisitions driven by stock overvaluation generate synergies? 
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The evidence above is consistent with the notion that overvalued acquirers pay especially high 
premiums in acquisitions and earn very negative bid-period returns. One alternative strategy for a firm to 
take advantage of its temporary overvaluation would be to conduct a seasoned equity offering (Loughran 
and Ritter, 1995). Why don’t overvalued acquirers conduct an equity offering instead of undertaking a 
stock-swap acquisition? Shleifer and Vishny (2003) answer this question by suggesting high synergies 
possibly generated from mergers but not from equity offerings (p. 302-303). Significant enough synergies 
could also justify the high premiums paid to targets by overvalued acquirers (Section 4). To directly 
address the question of whether acquisitions driven by stock overvaluation generate larger and positive 
synergies than other acquisitions, we examine operating performance following the merger. An 
examination of post-completion operating performance sheds light on the source of economic gains or 
losses associated with the mergers, and allows us to evaluate whether the merger creates real value for 
acquiring-firm shareholders. 
We employ two different methods to examine abnormal changes in operating performance after 
mergers. The first method follows Healy, Palepu, and Ruback (1992). Our primary measure of operating 
performance is earnings before interest, taxes, depreciation and amortization (EBITDA, also called 
operating income before depreciation) divided by the market value of the assets at the beginning of the 
fiscal year.13 Market value of assets is the market value of common equity plus the book values of 
preferred stock and long- and short-term debt net of cash. We call this measure operating ROA. Operating 
ROA can be decomposed into asset turnover, calculated as sales divided by the market value of assets at 
the beginning of the fiscal year, and operating profit margin, calculated as EBITDA divided by Sales. 
Asset turnover measures the productivity of existing assets. 
 
                                                 
13 Healy, Palepu, and Ruback (1992) argue that the rationale for using the market value of the assets rather than the 
book value to deflate operating income is that market value represents the opportunity cost of the assets and 
therefore facilitates inter-temporal and cross-sectional comparisons. Furthermore, using the market value of assets 
mitigates any effects arising from the choice of the accounting method for mergers (pooling vs. purchase). Our 
results are also robust to the use of book value of assets as the denominator. 
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We calculate operating performance for the merged firm for nine fiscal years (years -3 to +5) 
surrounding the merger completion year (year 0). In the pre-merger years, operating performance is 
calculated as the weighted average of the performance of the acquirer and target (weighted by the market 
values of assets for the two firms at the beginning of each fiscal year). We then find the industry median 
operating performance for the merged firm for the same fiscal years, which in the pre-completion years is 
the weighted average of the industry median operating performance for the acquirer and target (weighted 
by the market values of assets for the two merging firms at the beginning of each fiscal year and using the 
48 industry categories defined as in Fama and French (1997)). Abnormal operating performance is 
calculated as the difference between operating performance for the merged firm and the industry median 
operating performance. We then run cross-sectional OLS regressions to compute abnormal changes in 
performance due to the mergers, 
                                          .                               (6) 
 
The explanatory variable,                 , is the abnormal operating performance (operating 
ROA, asset turnover, or operating margin) for the merging firms in acquisition i, calculated as the median 
in the pre-merger years (years -3 to -1). The dependent variable,                  , is the abnormal 
operating performance during the post-merger years, calculated as the median in years +1 to +5. The 
slope coefficient  captures the correlation in abnormal performance between the pre-and post-merger 
years (i.e., persistence in operating performance for a given firm). The intercept  measures the average 
change in the industry-adjusted abnormal performance that is due to the merger, and is our main 
coefficient of interest. This method, proposed by Healy, Palepu, and Ruback (1992), has been adopted by 
many studies to examine changes in operating performance after mergers (Mitchell and Mulherin, 1996), 




and Ofek, 1995), share repurchases (Nohel and Tarhan, 1998), seasoned equity offerings (Fu, 2010), 
privatization (Boubakri and Cosset, 1998), and bankruptcy (Hotchkiss, 1995). 
The top panel of Table 6 contains estimates of intercept from Eq. (6) for the various categories of 
bidders (OV, NOV, and cash) analyzed in this paper. The point estimates suggest significant deterioration 
in operating performance (both operating ROA and asset turnover) following acquisitions by overvalued 
bidders, while the same is not true for NOV stock-swap bidders (no significant change in performance) or 
cash bidders (significant improvement in performance). For example, the point estimates suggest that 
mergers by overvalued acquirers are followed by an abnormal reduction of 0.93% in operating ROA, after 
controlling for industry peer performance and any time-series performance persistence of merging firms. 
Acquirers driven by stock overvaluation seemingly experience significantly abnormal declines in 
operating performance after mergers, largely attributable to a significant drop in the productivity of assets, 
while other types of bidders do not. 
The last column in Table 6 addresses the issue of whether overvalued firms generally underperform 
around the dates of mergers in this sample (even if they didn’t pursue a merger) or whether the decline in 
operating performance is attributable to the transaction itself. In other words, we try to answer the 
question: what would have happened if these overvalued acquirers had not pursued the acquisition. We 
match each OV acquiring firm in the sample to a non-merging overvalued firm that: a) exists for at least 
seven fiscal years centered on the merger completion year; b) does not conduct an SEO or acquisition in 
that seven-year window14; c) is in the same industry as the acquirer; d) has total assets of 50%-150% of 
the acquirer; e) has Tobin’s Q of 50%-150% of the acquirer; f) has a buy-and-hold return in the year 
before merger announcement of 50%-150% of the acquirer;  and g) has the closest Ln(M/V) measure 
(Table 2) to the acquirer (but not more than 50% larger or smaller) in the year prior to merger 
announcement. This procedure yields 326 matched control firms for the 425 OV acquirers. For these 
                                                 
14 Our results and conclusions in all the following tables do not change if we instead define this window to be a 
three-year window centered on the merger completion year.  
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similarly-overvalued, but non-merging, control firms we compute abnormal operating performance over 
the same fiscal years as we do for the event (acquiring) firms.  
As can be seen in the final column of Table 6, matched similarly-overvalued firms that do not 
participate in acquisitions on average do not incur a decline in performance around the time of the 
mergers in our sample. This contrasts starkly with the significant declines in performance observed for the 
overvalued acquirers documented in the first column of the table. These results suggest that overvalued 
acquirers suffer significant declines in operating ROA, at least partly caused by declines in the efficiency 
of asset usage, while other types of acquirers and similarly-overvalued non-acquiring firms do not. The 
comparison with non-acquiring overvalued firms suggests that the overvalued acquirers in our sample 
may have been better off had they not pursued their acquisitions.  
Barber and Lyon (1996) emphasize the importance of matching firm size and pre-event operating 
performance in estimating firms’ abnormal performance following corporate events (such as mergers). 
Therefore, our second method adopts this approach. For every bidder and target firm, we find a control 
firm in the same industry that (a) has total assets of 50%-150% of the merging firm, and (b) has the 
closest operating ROA to the merging firm in the fiscal year before the merger. As a result, we have a pair 
of control firms for each pair of merging firms. Control firms are required to exist for at least three years 
and not conduct seasoned equity offerings or be involved in acquisitions in the following five years. The 
weighted-average operating performance of the control firm pair is calculated each year as the benchmark 
performance for the merged firm. The weights are the market values of assets of the two merging firms at 
the beginning of the merger completion year. Abnormal operating performance is the difference in 
operating performance of the merged firm and its benchmark. We compute the median abnormal 
operating performance over the five post-merger years to make statistical inferences. The results are 
presented in the bottom panel of Table 6.  
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Our conclusions using this empirical method are similar to those reported above. Specifically, 
overvalued acquirers appear to substantially and significantly underperform the weighted-average 
benchmark of matched firms that had similar size and ROA as the bidder in the pre-merger years. Using 
the Barber and Lyon method, it appears that NOV stock-swap bidders, cash bidders, and the similarly-
overvalued but non-merging control firms also experience significant declines in both operating ROA and 
asset turnover in the following years, but their declines in performance are substantially lower in 
magnitude than those experienced by overvalued (OV) bidders, largely because these firms experience 
(offsetting) improvements in operating margins that OV acquirers do not. 
To summarize, the post-acquisition operating performance evidence in Table 6 suggests that 
overvalued  acquirers significantly underperform in the years after their acquisitions, both in industry- and 
pre-event adjusted terms (the Healy, Palepu, and Ruback (1992) technique) and relative to firms matched 
on size and pre-event performance (the Barber and Lyon (1996) technique). Interestingly, this is not true 
(or much lower in magnitude) for NOV stock-swap bidders or cash bidders, nor is it true for industry 
peers that are similarly overvalued at around the same time as the acquisition takes place. Combined, this 
evidence suggests that overvalued acquirers do not seem to reap operating synergies from acquisitions. 
“Synergies” in deals consummated by overvalued acquirers are very likely negative, or at best much 
lower than synergies in deals by acquirers not using overvalued stock as a method of payment.  
 
6. What if overvalued acquirers had not pursued stock acquisitions? 
Thus far, our evidence suggests that acquirers in OV acquisitions overpay for their targets and that 
these acquisitions generate little (or, worse, negative) long-run operating synergies. Both these factors 
challenge the notion that acquisitions by overvalued acquirers create value for acquirer shareholders. 
However, one might still argue that if an overvalued acquirer does not pursue an acquisition, stockholders 
might incur even larger losses in value in the long run. Savor and Lu (2009) find that stock bidders that 
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fail to complete their deals (i.e., failed bidders) realize worse long-run abnormal stock returns than do 
stock bidders that consummate their deals, and argue that completed stock acquisitions create value for 
acquirer shareholders.15  
We address the same issue from a different perspective – comparing the long-run abnormal returns of 
successful OV acquirers with those of control firms that are in the same industry, similarly overvalued at 
the same time, have similar size, Tobin’s Q and prior returns, but have not pursued an acquisition or 
equity offering (the similarly-overvalued, non-merging peers identified in Table 6). 16  In part, this 
evidence complements the findings in Table 6 and addresses a missing piece of the value creation puzzle. 
In addition, these results also help compare and contrast our paper, and our OV-acquirer sample selection 
process specifically, with the existing literature (especially Savor and Lu (2009), which compares 
successful and unsuccessful bidders without conditioning on overvaluation).  
We compute long-run abnormal returns using three different approaches. The first is market-adjusted 
buy-and-hold returns, defined as follows: 
 
                    
 
                    
 
        (7) 
 
where t=0 is the month of acquisition announcement.      is the monthly return for stock i in month t, 
     is the monthly return for the CRSP value-weighted index in month t,   is the holding period, 
respectively 24, 36, and 60 months.  
                                                 
15 However, Savor and Lu (2009) show in their Table IX (p.1084) that acquirer shareholders react positively to 
announcements of bid termination, suggesting shareholders do not think that completing the deal creates value. 
16 In a similar spirit, DeAngelo, DeAngelo, and Stulz (2010) examine the popular view of market timing as a 
primary motivation for SEOs. They find that although SEO firms have high M/B ratios and high recent stock returns 
prior to the announcement, the vast majority of firms with high M/B ratios and high recent stock returns do not issue 
stock. They therefore conclude that “The problem for the market-timing explanation is that, paraphrasing Sherlock 
Holmes, many ‘dogs don’t bark’ at times when, according to theory, they should be barking.” (p.276). One way to 
think about our tests is that we investigate if “dogs that should bark but didn’t bark” are penalized by poor long-run 
returns, and in particular whether their long-run returns are worse than those for similar firms that did undertake an 
acquisition. 
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Our second method is the calendar-time portfolio approach proposed by Mitchell and Stafford 
(2000). Specifically, in each month during our sample period we form a portfolio consisting of OV 
acquirers that have announced an eventually-completed acquisition within the previous 24, 36, or 60 
months. The portfolio is rebalanced monthly to add the OV acquirers that have just announced an 
acquisition and drop the firms that reach the end of the holding period. We form another portfolio 
consisting of the non-merging OV peers, and the timing of their inclusion into (and exclusion from) the 
non-merging portfolio is the same as for their matched OV acquirer. We calculate the monthly equal-
weighted excess returns of the event and control portfolios and run time-series regressions of the portfolio 
excess returns on the Fama and French three factors,  
 
                                             .   (8) 
 
The regression intercepts    measure the average monthly abnormal return for portfolio p over the 
holding period.  
       Our third approach is Ibbotson’s (1975) returns across time and securities (IRATS) method combined 
with the Fama-French three-factor model. We run the following regression in each event month j: 
 
                                             ,    (9) 
 
where      is the monthly return on stock   in the calendar month   that corresponds to the event month  . 
    is the month of the merger announcement. The abnormal returns during the holding period are sums 
of the intercepts of cross-sectional regressions over the relevant event-time periods.  
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Table 7 reports median long-run stock returns, contrasting OV acquirers with non-merging, but 
similarly overvalued, peers in the same industry. The columns labeled “Difference” report the median 
returns for a long-short portfolio that is long OV acquirers and short non-merging OV peers. In general, 
we find that OV acquirers realize significantly worse returns than their matched peers in the two to five 
years after acquisitions, with the differences appearing especially strong in market-adjusted buy-and-hold 
returns and using the IRATS method. Of particular interest, the market-adjusted buy-and-hold returns are 
negative for both OV acquirers and non-merging overvalued peers (reflecting the correction of 
overvaluation), but substantially more negative for overvalued firms that actually complete an acquisition 
compared to their similarly overvalued peers. 
This long-run stock return evidence, coupled with the operating performance results in Table 6, 
succinctly summarizes the net effect of acquisitions by overvalued acquirers: the net effect of 
overpayment, negative deal synergies, and the correction of ex-ante overvaluation is clearly detrimental 
for acquirer shareholders. Furthermore, it suggests that shareholders of overvalued firms would be better 
off if managers of their firms did not pursue the acquisitions. 
 
7. Why do value-destroying acquisitions by overvalued acquirers happen? 
Why would overvalued acquirers pay such high premiums to their targets while the post-completion 
performance is so poor? One possibility is that agency problems drive acquisition activity by overvalued 
acquirers, especially if unchecked by strong internal and external corporate governance. Jensen (2005) 
suggests that equity overvaluation generates substantial agency costs, and as an example he suggests that 
ill-conceived acquisitions, driven by stock overvaluation, reflect these agency costs. Overvaluation, by 
definition, implies that the firm will be unable to deliver the operating performance priced into its pre-
acquisition stock price. Managers under pressure to meet such unachievable expectations potentially take 
risky actions (asset substitutions) that harm shareholder value, such as poorly-conceived acquisitions. 
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Jensen points out that the prevalence of equity-based managerial compensation in the past two decades, 
such as incentive bonuses based on stock price appreciation and stock option grants, exacerbates this 
problem.  
Extant studies of CEO compensation and incentives suggest this is highly plausible. For instance, 
Fich, Starks, and Yore (2008) argue that executive compensation schemes often motivate CEOs to engage 
in deal-making activity. They find that total CEO compensation increases upon the completion of many 
large corporate transactions, such as mergers and acquisitions, even when the deals are not expected to 
improve firm value. Grinstein and Hribar (2004) show that CEOs having more power to influence board 
decisions receive significantly larger M&A bonuses, but these bonuses are not related to deal 
performance. Based on 1,508 acquisitions between 1993 and 2000, Harford and Li (2007) find that 
acquirer CEOs are significantly better off due to new stock and option grants following acquisitions. The 
addition of large new grants offset the wealth reduction of the CEO’s existing portfolio even for poorly 
performing firms. Moreover, CEO’s pay and wealth become insensitive to poor performance, but remain 
sensitive to good performance, after acquisitions. Combined, these studies suggest that it is possible that 
the results in this paper can be explained from an agency cost perspective. 
We examine whether acquisitions by overvalued acquirers are motivated by CEO enrichment rather 
than stockholder wealth creation (which seems unlikely given our results so far), and whether weak 
governance encourages such a pattern. In Panel A of Table 8, we follow the empirical approach in 
Harford and Li (2007) and decompose CEO compensation into two components: cash payments 
(including annual salary and bonus compensation) and new grants of restricted stock and stock options. 
We calculate the medians of these two variables in the fiscal year before merger announcement with their 
values in the fiscal year following merger completion, and compare the increases for OV acquirers with 
increases for CEOs of their similarly-overvalued, non-merging peers (as described in Table 6).  
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Our sample consists of 166 OV acquirers and 90 similarly-overvalued, non-merging peers with 
available compensation data in Compustat’s ExecuComp database. We find that acquirer CEOs enjoy a 
considerable increase in their wealth after completing acquisitions. Of the two groups in Table 8, CEOs of 
overvalued firms that engage in acquisitions (OV column) experience the largest increase in wealth 
despite having poor acquisition performance (high premiums, low or negative synergies). Compared to 
the year prior to announcement, the median CEO of an overvalued acquirer obtains an increase in grants 
of options and/or restricted stock following completion of $1.28 million versus $0.72 million for CEOs of 
similarly-overvalued, non-merging peers. The median value of cumulative grants from the year prior to 
announcement to the year after completion is $9.6 million for the CEOs of overvalued acquirers, 
compared to $4.9 million for CEOs of similarly-overvalued, non-merging peers, and this difference is 
statistically significant at better than the 5% level. Compared to CEOs of similarly-overvalued firms that 
do not engage in acquisition activity, therefore, CEOs of overvalued acquirers experience considerable 
increases in wealth (while their shareholders do not). 
Why does the firm’s governance structure allow this to occur? In Panel B of Table 8 we present 
governance metrics for the samples of overvalued firms (measured in the fiscal year immediately prior to 
the acquisition/match year). Following prior literature, firms are considered to have weak governance if 
the board size is larger (Jensen, 1993; Yermack, 1996), the board is weak (proxied by the tenure of the 
CEO greater than the median: Hermalin and Weisbach, 1998; Harford and Li, 2007), the BCF index is 
high (managers are entrenched by anti-takeover provisions: Bebchuk, Cohen, and Ferrell, 2009), or 
blockholders or executives have low ownership stakes in the firm (Jensen and Meckling, 1976). As can be 
seen in Panel B of Table 8, these governance metrics suggest that overvalued firms that engage in 
acquisitions have significantly weaker governance than similarly-overvalued peers that do not make 
acquisitions. Specifically, OV acquirers have significantly larger boards, higher BCF index (indicative of 
greater entrenchment), and weaker external monitoring (indicated by lower ownership by blockholders). 
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In summary, we find that CEOs of overvalued firms are richly rewarded for acquisition activity that 
does not benefit their shareholders, and that the governance structure of these firms appears to exacerbate 
the agency problems that lead to this outcome. This is consistent with the contention in Jensen (2005) that 
equity overvaluation generates substantial agency costs potentially leading to ill-conceived acquisitions 
that destroy shareholder wealth. 
 
8. Conclusion 
Stock-swap acquisitions by overvalued acquirers could benefit acquirer shareholders, but only if the 
premium paid to the target is not too high and/or if the acquisition generates substantial synergies. The 
evidence in this paper suggests that neither of these conditions appears to be satisfied. Overvalued 
acquirers pay high premiums to their targets and generate negative synergies in the post-acquisition years 
(leading to substantial declines in operating performance). This results in substantial declines in the value 
of the acquirer’s stock over the bid period and negative long-run abnormal stock returns that appear larger 
in magnitude than necessary to correct ex-ante overvaluation. We also show that acquirer CEOs extract 
considerable rewards for themselves despite the poor performance for their shareholders, highlighting an 
agency concern that is potentially exacerbated by weak corporate governance. 
Our findings cast substantial doubt on the effectiveness of acquirers’ use of temporarily overvalued 
stock in stock-swap mergers and acquisitions. Significant overpayment for the target and negative long-
run synergies appear to erode most of the gains that would otherwise accrue to the shareholders of an 
overvalued acquirer buying a less-overvalued target. Perhaps most importantly, our evidence suggests that 
shareholders would be better off if an overvalued firm did not pursue an acquisition in the first place, 
even accounting for the correction of overvaluation. Overall, our findings cast doubt on the notion that 




A firm’s log market-to-book equity ratio (M/B) can be decomposed into two items, 
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where M is the observed market value of equity and B is the book value of equity. V stands for the 
intrinsic value of equity, which is unobservable. Previous studies, for example Lee, Myers, and 
Swaminathan (1999), Ang and Cheng (2006), and Dong, et al. (2006), use a residual income model to 
estimate V. However the residual income model relies on a number of fairly restrictive assumptions, and, 
more importantly, the use of analyst forecasts (to compute residual income) would bias our tests toward 
large M&A transactions.  
RRV (2005) relax the residual income model and assume that a firm’s intrinsic value is a linear 
function of its book value of equity, net income (i.e., the growth of book value of equity), and leverage. 
The parameters of the linear function are allowed to vary over time and across industries to reflect the 
variation in investment opportunities across times and industries. The parameters also capture 
differences in discount rates amongst firms. Specifically,  
    (A2) 
 stands for the absolute value of net income of firm i at time t.  is an indicator variable which 
equals one for firm-years with negative net income, and zero otherwise. LEV is the market leverage ratio. 
The subscript j stands for industry.  captures the deviation of intrinsic value from the observed market 
value of equity and, therefore, is a natural proxy for misvaluation. 
We run cross-sectional regressions of Eq. (A2) for each industry and each year to estimate the 
parameters . We use the industry classification scheme developed by Fama and French (1997) to 





classify firms into 12 industries, and find similar results to RRV (2005). These three variables, i.e., book 
value of equity, net income, and leverage ratio, are able to explain the within-industry cross-sectional 
variations of market value of equity well, with regression R2s over 80% for almost all industries.  
The residual from Eq. (A2) ( ) can be interpreted as the firm-level mispricing at a point of time. 
Previous studies suggest, however, that there is an important industry-specific component of misvaluation, 
and the magnitude of industry-level misvaluation also varies over time. So the effective mispricing for a 
firm is the sum of firm-level and industry-level mispricing. Following RRV (2005), we take the time-
series average of , the estimated  from Eq. (A2), to compute the long-run parameters  
. The final measure of RRV mispricing is: 
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The sample of mergers and acquisitions from 1985-2006. 
 
The sample consists of 1,319 stock-financed and 671 cash-financed mergers and acquisitions that are 
announced and completed during 1985 - 2006 in the U.S. The table presents the sample distribution by 
the calendar year of acquisition announcement. The following criteria are used to select the sample from 
the SDC Domestic M&A database: (1) Both the acquirer and target are public firms listed on the NYSE, 
AMEX, or Nasdaq; (2) The deal value is at least $10 million (in 2006 dollars) and at least 1% of the 
acquirer’s market value of equity as of the month end before merger announcement; (3) The acquirer 
controls less than 50% of the target’s shares prior to the announcement and owns 100% of the target’s 
shares after the transaction; (4) The method of payment is either 100% cash or 100% stock; (5) Both the 
acquirer and the target have positive book value of assets (AT) and book value of equity (CEQ) in 
Compustat as of the end of the fiscal year prior to announcement, and share price and shares outstanding 
data available in the CRSP as of the end of the month prior to announcement.  
 
Year Stock Cash 
1985 27 33 
1986 16 48 
1987 24 33 
1988 16 38 
1989 17 20 
1990 15 11 
1991 26 4 
1992 26 7 
1993 25 18 
1994 92 36 
1995 121 36 
1996 105 29 
1997 167 37 
1998 174 43 
1999 134 48 
2000 110 39 
2001 79 23 
2002 23 21 
2003 39 30 
2004 40 36 
2005 22 34 
2006 21 47 
 
Total 1,319 671 
  
34 
Table 2  
Overvaluation of merging firms. 
 
This table presents averages of a measure of overvaluation for bidders and target in the sample described in Table 1. Overvaluation is measured as proposed by 
Rhodes-Kropf, Robinson, and Viswanathan (2005) and described in the Appendix. Overvaluation is measured at three points in the life of each deal: 42 trading days before 
announcement (AD-42), one day before announcement (AD-1), and on the day of deal completion (CD). For all three measures, the book value of equity (from Compustat) 
is measured as of the end of the fiscal year immediately preceding deal announcement. The market-to-book equity ratio is decomposed into two components: misvaluation 
and long-run investment opportunities, Ln(M/B) = Ln(M/V) + Ln(V/B). The last three rows of the table describe the measure of misvaluation (Ln(M/V)). The last three 
columns report the differences in valuation ratios. Statistical significance is examined with t-tests: *, **, or *** indicates that the difference is significantly different from 
zero at the 10%, 5%, or 1% level, respectively.  
 
Valuation ratios Bidders Targets Stock bidders Targets of 
stock bidders 
Cash bidders Targets of 
cash bidders 
Stock bidders 
– Cash bidders 
Stock bidders 
– Stock targets 
Cash bidders   
– Cash targets 
Ln(M/B) _AD-42 1.02 0.71 1.14 0.79 0.78 0.54     0.36***      0.35***   0.24*** 
Ln(V/B)_AD-42 0.52 0.58 0.56 0.60 0.46 0.54    0.10***           -0.04**          -0.08** 
Ln(M/V)_AD-42 0.50 0.13 0.58 0.19 0.32 0.01    0.26***      0.39***           0.31*** 
Ln(M/V)_AD-1 0.51 0.21 0.60 0.26 0.33 0.10    0.27***      0.33***           0.22*** 




Acquirer, target, and deal characteristics. 
 
The sample consists of 425 OV mergers, 404 NOV mergers, and 671 cash mergers out of the sample 
described in Table 1. The classification of stock-swap acquisitions into OV and NOV groups is based on 
the relative overvaluation measures proposed by Rhodes-Kropf, Robinson, and Viswanathan (2005) (and 
described in the Appendix) measured 42 trading days prior to the merger announcement. NOV stock 
mergers are defined as those for which the acquirer is either a) not overvalued in absolute terms; or b) not 
more overvalued than its target. For the remaining stock-swap acquisitions, we divide the sample into 
halves using the median of the difference in overvaluation between the acquirer and target, and stock-
swap acquisitions with the greatest difference in overvaluation are labeled OV stock mergers. This table 
reports medians of the following firm characteristics and performance variables as of (unless otherwise 
noted) the fiscal year ending immediately prior to the merger announcement: assets, MVE (market value 
of equity 42 trading days before announcement), price-to-earnings (P/E) ratio, leverage (debt/market 
value of assets), Tobin’s Q (market value of assets divided by the book value of assets), operating ROA 
(operating income/market value of assets at the beginning of fiscal year), asset turnover (sales/market 
value of assets at the beginning of fiscal year), sales growth (from fiscal year t-2 to fiscal year t-1), the 
acquirer’s market-adjusted 12-month stock return (buy-and-hold return during the 12 months prior to the 
announcement divided by the contemporaneous CRSP valued-weighted market return), and the standard 
deviation of the acquirer’s stock returns (over the period from trading day -253 to -42 relative to the 
announcement date). Total assets and market value of equity are expressed in real terms (2006 dollars). 
Hostile, Compete, Tender, Tarterm, Bidlock, and Toehold are indicator variables of deal characteristics 
that equal one if the deal is hostile, has more than one acquirer bidding for the target, is a tender offer, 
includes target termination fees, includes bidder lockup provisions, or involves a bidder that holds 0.5% 
or more of the target stock prior to the announcement, respectively (and zero otherwise). Means are 
reported for all indicator variables. % of horizontal is the percentage of acquisitions that are horizontal 
mergers, defined as mergers in which both the acquirer and the target are in the same Fama-French 48 
industry. % in waves is the percentage of acquisitions that occur during merger waves, where merger 
waves are identified as in Harford (2005). Wilcoxon sign rank tests are used to test the difference in 
medians and Fisher’s Exact tests are used to test the difference in means of all indicator variables. 
*, **, or 
*** indicates that the value in the NOV or Cash acquisitions column is significantly different from the 







 Stock Acquisitions 
 Cash acquisitions  OV  NOV  
 Bidder Target  Bidder Target  Bidder Target 














































Standard deviation of the 
































    0.06*** 
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Table 4   
Acquisition premiums. 
 
This table presents descriptive statistics for acquisition premiums paid by acquirers to targets and for 
acquirer bid-period cumulative abnormal returns (CAR). Acquisition premiums are measured in two 
different ways. The first measure (AP1) is the cumulative abnormal return to the target during the bid 
period, i.e., from 42 trading days before merger announcement to the date of deal completion (Schwert, 
1996). Cumulative abnormal returns are estimated using the market model with the CRSP valued-
weighted index as the market portfolio. The parameters of the market model are estimated based on daily 
stock returns from trading days -253 to -45. The second measure of acquisition premium (AP2) is 
estimated for stock-swap acquisitions only, and is the exchange ratio divided by the relative stock price of 
the target and bidder 42 trading day before the announcement. The classification of stock acquisitions into 
OV and NOV groups is described in Table 3. The last two columns report the differences in means and 
medians. Statistical significance is examined with t-tests (means) and Wilcoxon-Mann-Whitney tests 
(medians): *, **, or *** indicates that the difference is significantly different from zero at the 10%, 5%, or 1% 
level, respectively. 
 
 OV NOV Cash Diff 
(OV – NOV) 
Diff 
(OV– Cash) 
AP1 = Target bid-period CAR [-42, completion]   
Mean 
 






   35.16*** 
  




AP2  =( 
               
                             
        
Mean 
 
   68.51*** 
 
      37.15*** 
 






   44.97*** 
 








Three-day target abnormal announcement returns [-1,+1] 
Mean 
 
   19.70*** 
 
   14.24*** 
 
   28.40***    5.46*** 
 
   -8.70*** 
Median 
 
   16.56*** 
 
   10.93*** 
 
   21.68***    5.63*** 
 
   -5.12*** 
 
Acquirer bid-period CAR [-42, completion] 
Mean 
 




           1.72 
 
  -17.57*** 
 








          -0.09 
 
   -9.61*** 
 




Table 5  
Can acquirer, target, or deal characteristics explain the higher premiums paid by overvalued acquirers? 
The table reports the results from ordinary least squares regressions of acquisition premiums on merging firm and deal 
characteristics. The samples only include stock-swap acquisitions. In Columns 1-3 the dependent variable is the target’s cumulative 
abnormal returns from 42 trading days prior to announcement to merger completion (AP1 from Table 4). In Columns 4-6 the 
dependent variable is the exchange ratio divided by the relative stock prices of the target and acquirer 42 trading days before 
announcement (AP2 from Table 4). OV is an indicator variable that equals one if the deal is an OV stock-swap merger (defined in 
Table 3), and zero otherwise. ROV is the difference in Ln(M/V) between the acquirer and target (as in Table 2) 42 trading days 
prior to the merger announcement, winsorized at the 1%/99% level. RET_12 indicates market-adjusted 12-month stock returns 
(buy-and-hold returns during the 12 months prior to the announcement divided by the contemporaneous CRSP valued-weighted 
market return), and STDEV indicates the standard deviation of returns over the period from trading day -253 to -42 relative to the 
announcement date. All other variables are defined in prior tables. All regressions contain intercepts whose coefficients are not 
reported. *, **, or *** indicates that the regression coefficient is significantly different from zero at the 10%, 5%, or 1% level using t-
tests based on standard errors that are robust to heteroskedasticity. 
 
Acquisition Premium: AP1  AP2 
Independent variable (1) (2) (3)  (4) (5) (6) 
OV 11.17***    9.74**   
ROV  13.87*** 14.55**   7.21** 5.50 
Log(MVE) (acquirer) 5.80*** 3.49*** -0.71  11.21*** 10.09*** 7.98 
Log(MVE) (target) -8.79*** -7.32*** -6.87***  -8.67*** -8.22*** -6.35** 
Tobin’s Q (acquirer) 0.07 -0.19 1.21  0.02 -0.19 -0.63 
Tobin’s Q (target) -0.14 0.29 0.73  0.20 0.31 0.40 
Leverage (acquirer) -18.11** -25.01*** 0.91  -29.33*** -33.48*** -41.59 
Leverage (target) 14.49** 16.40** 11.49  13.55* 14.24* 3.97 
Operating ROA (acquirer) -8.70 -15.58 -67.38  -3.69 -8.07 -52.48 
Operating ROA (target) 18.95* 16.98 2.77  13.30 11.17 -27.25 
RET_12 (acquirer) -0.01 -0.01 -0.11*  0.06* 0.06* 0.06 
RET_12 (target) -0.21*** -0.20*** -0.21***  -0.06** -0.06** -0.12* 
STDEV (acquirer) 2.15 -1.10 -2.11  -0.65 -3.09 -17.12** 
STDEV (target) -0.40 -0.62 -2.76   4.62*** 4.55*** 6.20** 
Hostile 38.38*** 39.05*** 23.12  32.36* 34.49** 65.08*** 
Compete 3.31 0.75 -0.92  0.44 -3.54 -17.03 
Tender -5.31 -14.07 -3.77  -15.05 -23.39** -58.07 
Tarterm 5.00* 7.71*** -6.14  0.53 5.03 -2.41 
Bidlock -0.35 -1.97 -0.11  10.04*** 8.50** 10.08 
Toehold -6.36 -0.55 7.94  -4.78 -3.73 4.13 
        
Year fixed effects No Yes Yes  No Yes Yes 
Acquirer fixed effects No No Yes  No No Yes 
Number of observations 1,198 1,198 1,198  1,198 1,198 1,198 
Adjusted R2 0.189 0.224 0.324  0.126 0.137 0.178 
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Table 6    
Abnormal changes in operating performance after mergers. 
 
This table reports abnormal changes in operating performance after mergers for acquirers and 
overvalued non-acquirers. There are two metrics used to assess post-merger abnormal changes in 
operating performance. The first is based on Healy, Palepu, and Ruback (1992). For the first three 
columns, we calculate operating performance for the merged firm for nine fiscal years surrounding the 
merger completion year (years -3 to +5 relative to the merger completion year (0)). In the pre-merger 
years, this is calculated as the weighted average of the performance of the acquirer and target (with 
weights relative to the market values of assets for the two firms at the beginning of each fiscal year). We 
then find the industry median operating performance for the merged firm for the same fiscal years, which 
in pre-merger years is the weighted average of the industry median operating performance for the acquirer 
and target (with weights relative to the market values of assets for the two merging firms at the beginning 
of each fiscal year and 48 industry categories defined as in Fama and French (1997)). Abnormal operating 
performance is calculated as the difference between operating performance for the merged firm and the 
industry median operating performance. We then run a cross-sectional regression of the median post-
merger abnormal performance (years +1 to +5 relative to the merger completion year (0)) on the median 
pre-merger abnormal performance (years -3 to -1 relative to the merger completion year). The regression 
intercept is interpreted as the change in abnormal performance due to the merger, and is displayed in the 
table. In the final column we replicate this procedure for non-merging firms that are approximately as 
overvalued as the acquirer in the year prior to merger announcement. Specifically, for each OV acquiring 
firm in the sample we identify a non-merging OV firm that: a) exists for at least seven fiscal years 
centered the merger completion year; b) does not conduct an SEO or acquisition in that seven-year 
window; c) is in the same industry as the acquirer; d) has total assets of 50%-150% of the acquirer; e) has 
Tobin’s Q of 50%-150% of the acquirer; f) has a buy-and-hold return in the year before merger 
announcement of 50%-150% of the acquirer; g) has the closest Ln(M/V) measure (Table 2) to the 
acquirer (but not more than 50% larger or smaller) in the year prior to merger announcement. For this 
non-merging OV firm we replicate the procedure described above to compute abnormal operating 
performance over the same fiscal years as we did for the event (acquiring) firms. The second metric is the 
size and pre-merger performance match suggested by Barber and Lyon (1996). For the first three columns, 
for every acquirer and target firm we find a control firm that (a) has total assets of 50%-150% of the 
merging firm in the fiscal year before the merger, and (b) has the closest operating ROA to the merging 
firm in the fiscal year before the merger. As a result, we have a pair of control firms for each pair of 
merging firms. Control firms are required to exist for at least three years and not to conduct seasoned 
equity offerings or be involved in acquisitions in the following five years. The weighted-average 
operating performance of the control firm pair is calculated each year as the benchmark performance for 
the merged firm (with weights relative to the market values of assets for the two firms in the year before 
merger completion year (0)). Abnormal operating performance is the difference in the operating 
performance of the merged firm and this weighted-average benchmark, and the median abnormal 
operating performance over the first five post-merger years is displayed in the table. In the final column 
we replicate this procedure for non-merging firms that are approximately as overvalued as the acquirer in 
the merger announcement year (the non-merging OV firms are selected as described above). For the non-
merging OV firms we replicate the procedure of finding control firms based on total assets and ROA and 
reporting median abnormal operating performance over the following five fiscal years. p-values for tests 
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Long-run stock returns. 
This table presents median long-run stock returns of OV acquirers and their matched control firms. The non-merging OV control firms are in the same industry, 
similarly overvalued, have similar size and Tobin’s Q as the OV acquirers, but have not pursued an acquisition or SEO (as described in Table 6). We compute long-run 
abnormal returns using three different approaches: (1) Market-adjusted buy-and-hold returns:                     
 
                 
 
         where t=0 
is the month of acquisition announcement.      is the monthly return for stock i in month t,      is the monthly return for the CRSP value-weight index in month t   is 
the holding period (24, 36, or 60 months). (2) The calendar-time portfolio approach proposed by Mitchell and Stafford (2000). Specifically, in each month during our 
sample period we form two portfolios, one consisting of OV acquirers that have announced an eventually-completed acquisition within the previous 24, 36, or 60 months 
and the other consisting of corresponding control firms. The portfolios are rebalanced monthly to add the OV acquirers that have just announced an acquisition and drop 
the firms that reach the end of the holding period. We calculate the monthly equal-weighted excess returns of the OV acquirer and control portfolios and run time-series 
regressions of the portfolio excess returns on the Fama and French three factors,                                              . The regression 
intercepts    measure the average monthly abnormal return for portfolio p over the holding period, and are reported in the table. (3) Ibbotson’s (1975) returns across time 
and securities (IRATS) method combined with the Fama-French three-factor model. We run the following cross-sectional regression in each event month j:           
                                   , where      is the monthly return on stock   in the calendar month   that corresponds to the event month   (    is the 
month of the merger announcement). The reported abnormal returns during the holding period are sums of the intercepts from the cross-sectional regressions over the 






















































































Changes in CEO compensation and wealth after acquisitions and pre-acquisition governance. 
 
Panel A reports medians of CEO compensation data from Compustat’s ExecuComp database. The OV and Non-merging 
OV samples are described in Table 6. We require that CEOs be the same between the fiscal year before the acquisition 
announcement (ayr-1) and the fiscal year after the merger completion (cyr+1). Cash payment is the annual salary and bonus 
compensation. Grants are the total value of all restricted stock and options granted during the fiscal year. Cumulative grants are 
the value of grants from the announcement year (ayr) to year cyr+1. Dollar values are in thousands and adjusted to 2006 dollars. 
Panel B reports means of various governance characteristics for the year prior to the acquisition (or match) year. Board data is 
from the RiskMetrics (formerly IRRC) database. Board size is the number of directors on a board, and Strong board is an 
indicator variable that equals one for firms whose CEOs have served below the ExecuComp median years of CEO tenure, and 
zero otherwise. BCF index is from Bebchuk, Cohen and Ferrell (2009), and the data is from Lucian Bebchuk’s website. 
Blockholders are investors who own more than 5% of a firm’s outstanding shares, and outside ownership data is from the 
Thomson Reuters 13f database. Executive ownership is from Execucomp. The number of observations is in brackets. A t-test is 
used to test the differences in Board size and the BCF index, and Chi-square tests are used to test the difference in other 
variables. In both panels, *, **, or *** indicates that the difference is significantly different from zero at the 10%, 5%, or 1% level 
using a t-test, respectively. 
 
 






(OV - Non-merging OV) 
Year: ayr-1 
Cash payment 1,342 1,339 123 
Grants 2,219 1,538  1,257*** 
 
Year: cyr+1 
Cash payment 1,615 1,489 -3 
Grants 4,247 1,879   2,010*** 
 
Change from year ayr-1 to cyr+1 
Cash payment 210 220 -137 
Grants 1,281 715 902 
Cumulative grants 9,585 4,875   1,906** 
    
Number of observations 166 90 53 
    
 






(OV - Non-merging OV) 





























    
    
